drugset / Trial / NCT00598338

Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation

NCT00598338

Phase 3 Completed 516 enrolled Movetis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in the re-treatment of chronic constipation. Hypothesis: Retreatment is as effective and safe as treatment with prucalopride in patients with chronic constipation.

Timeline

Start
1999-04
Primary completion
2000-02
Completion
2000-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 4 mg Oral

Indications